Rationale: Islet1 (Isl1) has been proposed as a marker of cardiac progenitor cells derived from the second heart field and is utilized to identify and purify cardiac progenitors from murine and human specimens for ex vivo expansion. The use of Isl1 as a specific second heart field marker is dependent on its exclusion from other cardiac lineages such as neural crest.
T he recent discovery of the second heart field (SHF) has redefined the understanding of mammalian cardiac development. 1 While cells of the first heart field (FHF) form the early cardiac tube, the SHF contributes additional cells to the maturing heart through midgestation, ultimately forming large portions of the right ventricle, outflow tract, and atria. [2] [3] [4] SHF precursors have been characterized by expression of the homeobox gene Islet1 (Isl1). 2 Isl1 has been used to isolate putative cardiac progenitors from embryonic stem (ES) cell and induced pluripotent stem (iPS) cell cultures for the purpose of expansion and possible therapeutic application. [5] [6] [7] [8] [9] [10] In vitro studies and in vivo fate-mapping experiments suggest that Isl1 precursors are tripotential and give rise to endothelium, smooth muscle, and cardiac muscle. 7, 9 Although SHF-specific enhancer elements from several genes have been identified by the analysis of transgenic mice, 3, 11 no other specific markers for SHF precursors have been reported, emphasizing the importance that Isl1 has played as a specific marker of the SHF in cardiac and stem cell biology.
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Surprisingly, inactivation of various factors in SHF using Isl1 Cre/ϩ has resulted in mice with congenital heart defects involving the outflow tract (OFT) and aortic arch arteries that are strikingly similar to abnormalities produced by gene manipulation using Wnt1::Cre or Pax3 Cre/ϩ , which drive expression in cardiac neural crest. [12] [13] [14] This has led to the suggestion that SHF signals to neural crest via cell-cell interactions or secreted factors. However, an alternative hypothesis is that Isl1 Cre/ϩ is not restricted to SHF within the developing heart. To address whether Isl1 Cre/ϩ may also be expressed in the Wnt1 lineage of cardiac neural crest in addition to lineages of the SHF, we utilized a dual-fluorescent reporter allele that extends previously established recombinase-based intersectional strategies. [15] [16] [17] This dual fate-mapping approach uses a recently developed reporter mouse, RC::FrePe (R.D. Brust and S.M. Dymecki, unpublished data, 2011, and see Bang et al 18 ) that activates expression of enhanced green fluorescent protein (eGFP) within cells that have expressed both Flpe and Cre at any time and in any order within their lineage. In cells that have expressed Flpe alone, mCherry is expressed, while Cre activity alone is not reported. Thus, RC::FrePe indicates an intersectional population between expression domains as defined by expression of separate Flpe and Cre drivers.
Methods

Mouse Lines
A schematic of the RC::FrePe allele can be found within a summary of intersectional fate-mapping strategies and methods. 19 Genotyping information for all mouse lines can be found in the Online Data Supplement.
Histology and Immunohistochemistry
Samples were harvested, fixed overnight in 2% formaldehyde, and subsequently dehydrated through an ethanol series. Samples were then paraffin embedded and sectioned. For whole-mount staining of LacZ expression, samples were lightly fixed with 2% formaldehyde for 30 minutes and then incubated overnight with X-Gal. Antibodies used for immunohistochemistry were anti-dsRed rabbit polyclonal (Clontech, Mountain View, CA), anti-GFP goat polyclonal (Abcam, Cambridge, MA), and anti-␣SMA mouse monoclonal 1A4 (Sigma-Aldrich, St. Louis, MO). Quantitation of fluorescence was performed using ImageJ software (National Institutes of Health, Bethesda, MD).
Results
To validate the reporter activity of RC::FrePe in neural crest derivatives, we used 2 neural crest drivers, Wnt1::Flpe 20,21 and Pax3 Cre/ϩ , 22 to assess recombination and reporter activity (Online Figure IA through IO). Direct fluorescence of postnatal (P) day 0 Wnt1::Flpe; Pax3 Cre/ϩ ; RC::FrePe hearts demonstrates eGFP expression within the outflow tract where neural crest derivatives reside (Online Figure IM) . 22 Subsequent immunofluorescence confirms eGFP protein expression within the tunica media of the mature OFT, as expected for neural crest derivatives (Online Figure IO) . Relatively few mCherrylabeled cells remain after dual Flpe/Cre recombination, suggesting that most cardiac neural crest cells that expressed Wnt1::Flpe also expressed Pax3 Cre/ϩ (Online Figure IN) . An average of fluorescence from 9 stained Wnt1::Flpe; Pax3 Cre/ϩ ; RC::FrePe outflow tract sections revealed that 8.4%Ϯ3.6% (meanϮSD) of total staining was mCherry positive, while the majority, 91.6%Ϯ3.5%, was eGFP positive. Thus, the indicator allele RC::FrePe is sensitive to dual recombination, consistent with previous findings (R.D. Brust, and S.M. Dymecki, unpublished data, 2011, and see Bang et al 18 ). We did not detect any leakiness of eGFP or mCherry expression in these studies (Online Figure IB through IE).
We crossed Isl1 Cre/ϩ 23,24 mice with Wnt1::Flpe and RC::FrePe mice to detect overlap in Isl1-and Wnt1expressing populations ( Figure 1A through 1O ). In the absence of Flpe and Cre, only background fluorescence was observed in embryonic (E) day 12.5 embryos ( Figure  1A through 1E ). When Wnt1::Flpe was expressed in the presence of RC::FrePe, mCherry expression was observed by direct fluorescence in the craniofacial region populated by neural crest (Figure 1G , arrowhead) and in dorsal root ganglia (DRG, Figure 1G , arrows). The eGFP was not detected ( Figure 1H ). The mCherryϩ cells were detected by immunofluorescence in sections through the OFT endocardial cushions that are populated by cardiac neural crest by E12.5 ( Figure 1I ), while eGFP was not detected ( Figure 1J ). In the presence of both Wnt1::Flpe and Isl1 Cre/ϩ , mCherry expression persisted in craniofacial mesenchyme populated by cranial neural crest ( Figure 1L , arrowhead), and eGFP fluorescence was observed in DRGs ( Figure 1M, arrows) , consistent with the known expression of Isl1 in neural crest-derived DRGs. 25 Immunofluorescence confirmed expression of both mCherry ( Figure 1N ) and eGFP ( Figure 1O ) in sections through the endocardial cushions of the OFT, indicating that at least some cardiac neural crest derivatives in the heart have expressed Isl1 Cre/ϩ at some time in their development.
A transgenic mouse with an enhancer element derived from the Mef2c gene directing expression of Cre recombinase, Mef2c-AHF-Cre, is widely used to label SHF derivatives. 11 We crossed this mouse to Wnt1::Flpe and RC::FrePe but did not detect any evidence for overlap of expression domains at E12.5 ( Figure 1P through 1T) . This result indicates that Mef2c-AHF-Cre may be more restricted to SHF precursors than is Isl1 Cre/ϩ and also serves as an important negative control to minimize the chance that leaky expression explains the presence of eGFP in Wnt1::Flpe; Isl1 Cre/ϩ ; RC::FrePe embryos.
Analysis of P0 hearts of Wnt1::Flpe; Isl1 Cre/ϩ ; RC::FrePe and Wnt1::Flpe; Mef2c-AHF-Cre; RC::FrePe pups confirms the stark difference between Isl1 Cre/ϩ and Mef2c-AHF-Cre (Figure 2A through 2J and Online Figure II) . Both mCherry and eGFP are evident in the OFT of P0 Figure 2B and 2C) as visualized by direct fluorescence, and eGFP immunofluorescence is evident in the tunica media of the great vessels ( Figure 2D ) and in the leaflets of the aortic valve ( Figure 2E ). The eGFP expression is not detected in Wnt1::Flpe; Mef2c-AHF-Cre; RC::FrePe hearts ( Figure 2H through 2J) . The areas of fluorescence marked by either Isl1 Cre/ϩ or Mef2c-AHF-Cre with Rc::FrePe are within the fate-mapped domains marked by these drivers using R26 LacZ/ϩ (Online Figure II) . The eGFP expressing derivatives of Isl1 Cre/ϩand Wnt1::Flpe-expressing precursors are able to differentiate into smooth muscle, as evidenced by coexpression of eGFP and smooth muscle actin (SMA) in the proximal aorta of Wnt1::Flpe; Isl1 Cre/ϩ ; RC::FrePe pups ( Figure 2K through 2M, arrowheads). The eGFPϩ cells are observed near the branchial arches of Wnt1::Flpe; Isl1 Cre/ϩ ; RC::FrePe embryos as early as day E10.5 and within the aortic sac (Online Figure III) .
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Discussion
These results indicate that Isl1 Cre/ϩ is not restricted to SHF precursors of the mature heart. Rather, Isl1 Cre/ϩ labels both SHF precursors and also at least some cardiac neural crest cells. Isl1 is known to be expressed by other neural crest derivatives, including DRG and cardiac ganglia, 23, 25 but the demonstration of Isl1 Cre/ϩ expression by cardiac neural crest precursors demands reevaluation of its use as an SHF driver and reinterpretation of some prior studies. For example, both neural crest and SHF can give rise to smooth muscle. Given our results, it is now unclear whether some or all Isl1 derivatives in the OFT that express smooth muscle markers are neural crest or SHF derived. 2, 23, 24, 26 Our data suggest that at least some are of neural crest origin. Isolation of Isl1-expressing cells from ES or iPS cultures, or from embryos, for the purpose of expanding SHF precursors (see references listed in supporting information in the Online Data Supplement) 2, 6, 7, 9, 23 may actually result in the expansion of neural crest cells. Studies in which Isl1 Cre/ϩ has been used to manipulate gene expression in the SHF, and which have resulted in aortic arch and OFT defects, may need to be reexamined for the possibility of cell autonomous neural crest effects. Experimental approaches using multiple or alternative SHF drivers, such as Mef2c-AHF-Cre, and use of dual and intersectional fate-mapping approaches, such as the one described here, may define cardiac cell origins and fates more clearly than would using the Isl1 marker alone. Our studies emphasize the need for the identification of more specific molecular markers of SHF precursors. 
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